drugset / Trial / NCT00447213

A Study for Patients With Type 1 Diabetes Mellitus

NCT00447213

Phase 2/3 Completed 70 enrolled Eli Lilly and Company Alkermes, Inc. · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare the human insulin inhalation powder plus insulin glargine with injected insulin (regular human insulin or insulin lispro) plus insulin glargine on lowering the blood sugar level.

Timeline

Start
2007-04
Primary completion
2008-05
Completion
2008-05

Publications

  • Results Hitoshi Ishii, Satoru Tsujii, Masami Tanaka, Miyuki Furuya, Tadao Iburi, Rei Ueda, Sakura Okuyama, Risa P. Hayes, Masato Okamura, Kazuya Iwamoto, Eisei Oda. Development of IDSQ-J and assessment of reproducibility adequacy. Tonyobyo. 2009;52(3):209-221.

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled
Subject Insulin Protein / enzyme biologic Other
Subject Insulin Lispro Protein / enzyme biologic Other
Background insulin glargine Protein / enzyme biologic Other